ResearcherSechenov UniversityActive in the last 2 years
V. Egorov
Matched on ORCID iD 0000-0002-8805-7604; OpenAlex author ID A5044322710. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2013: 1 paper · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 7
- ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18479-z↗
- Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18212-w↗
- REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006248↗
- Pancreatectomy with En Bloc Superior Mesenteric Vein and All Its Tributaries Resection without PV/SMV Reconstruction for "Low" Locally Advanced Pancreatic Head… Co-author DOI 10.3390/cancers16122234↗
- [Endosonography in the T-staging of pancreatic cancer]. Last author PMID 25327670↗
- [Endoscopic ultrasonography in determining resectability of the pancreatic adenocarcinoma]. Last author PMID 25916136↗
- Computed tomography-based diagnostics might be insufficient in the determination of pancreatic cancer unresectability. Co-author DOI 10.4240/wjgs.v5.i4.83↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Allegra Ripolli · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Kongyuan Wei · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Emanuele F. Kauffmann · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Riccardo Casadei · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Sergio Alfieri · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Gregory G. Tsiotos · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Alessandro Zerbi · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Yuichi Nagakawa · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Niccolò Napoli · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Benedetto Ielpo · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Elena B. Rangelova · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Emilio Vicente · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Ugo Boggi · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Marc G. Besselink · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Giuseppe Fusai · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Roberto Coppola · 2 shared papers, 2025–2026 · strength 0.41
- Paper ASO Visual Abstract: Survival Benefit of Surgery Versus Oncology-Only Therapy in Artery-Involving Borderline Resectable… DOI 10.1245/s10434-025-18479-z↗
- Paper Survival Benefit of Surgery versus Oncology-Only Therapy in Artery-Involving Borderline Resectable and Locally Advanced… DOI 10.1245/s10434-025-18212-w↗
- Tatiana Dakhtler · 1 shared paper, 2024 · strength 0.20
- Elena N. Solodinina · 2 shared papers, 2014 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.